Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L01XC40 |
UNII: | P0GVQ9A4S5 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Programmed cell death protein 1 antagonist | FDA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Endometrial Neoplasms | 4 | D016889 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
Liver Neoplasms | 2 | D008113 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
Mesothelioma | 2 | D008654 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Carcinoma, Pancreatic Ductal | 2 | D021441 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Hereditary Breast and Ovarian Cancer Syndrome | 2 | D061325 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4298124 |
FDA SRS | P0GVQ9A4S5 |